Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Other Working Capital Changes (2021 - 2024)

Goldenwell Biotech filings provide 4 years of Other Working Capital Changes readings, the most recent being -$54.0 for Q4 2024.

  • On a quarterly basis, Other Working Capital Changes changed N/A to -$54.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$54.0, a 0.0% change, with the full-year FY2024 number at -$54.0, up 99.79% from a year prior.
  • Other Working Capital Changes hit -$54.0 in Q4 2024 for Goldenwell Biotech, roughly flat from -$54.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $62586.0 in Q1 2021 to a low of -$25372.0 in Q1 2023.
  • Median Other Working Capital Changes over the past 4 years was -$3747.0 (2022), compared with a mean of $3554.2.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 578.4% in 2023 and later skyrocketed 99.79% in 2024.
  • Goldenwell Biotech's Other Working Capital Changes stood at -$3690.0 in 2021, then fell by 1.73% to -$3754.0 in 2022, then crashed by 575.87% to -$25372.0 in 2023, then skyrocketed by 99.79% to -$54.0 in 2024.
  • The last three reported values for Other Working Capital Changes were -$54.0 (Q4 2024), -$54.0 (Q1 2024), and -$25372.0 (Q3 2023) per Business Quant data.